Stock Events

Biomarin Pharmaceutical (BMRN) Q3 2021 Earnings

28JulConfirmed
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-0.21
1.2
2.6
4.01

Details

Expected EPS
-0.11
Actual EPS
0.07
Surprise EPS
0.18
Surprise Percent
+163.64%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 0.07 per share for Q3 2021.

0 Comments

Share your thoughts